AI-Designed Drugs Are Entering Clinical Trials. The Pipeline Is Larger Than Most Engineers Realize.
4 min readOver 150 AI-designed drug candidates are in clinical trials globally — a 7x increase since 2022. AlphaFold 3 has compressed pre-clinical discovery from 4–6 years to 12–24 months. The first FDA approvals of AI-primary drug candidates are 3–5 years away.